Enhanced Delivery Epinephrine Compositions
A pharmaceutical composition with a polymer matrix and penetration enhancers like plant extracts and fatty acids addresses the challenge of mucosal barrier absorption, enhancing epinephrine delivery and bioavailability for rapid systemic action.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-10-31
- Publication Date
- 2026-03-04
AI Technical Summary
Existing pharmaceutical compositions face challenges in delivering active ingredients across mucosal barriers efficiently, particularly the oral and sublingual tissues, due to the barriers posed by the oral mucosa, which limits bioavailability and absorption rates.
The development of a pharmaceutical composition comprising a polymer matrix with epinephrine, adrenoceptor interacting agents, and penetration enhancers such as plant extracts and fatty acids, which enhance the permeability of the mucosal membranes, allowing for increased absorption and bioavailability of the active ingredient.
The composition significantly improves the absorption and bioavailability of epinephrine across mucosal surfaces, achieving enhanced delivery and rapid systemic action with increased convenience and patient compliance.
Smart Images
Figure 2026035600000014 
Figure 2026035600000015 
Figure 2026035600000016